You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Renal Pelvis Tumor

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Renal Cell Carcinoma, Adrenal Tumor, Nonfunctioning Kidney Trial (telesurgery by domestic surgical robot)

Not yet recruiting
  • Renal Cell Carcinoma
  • +13 more
  • telesurgery by domestic surgical robot
  • (no location specified)
Feb 12, 2023

Locally Advanced Bladder Urothelial Carcinoma, Locally Advanced Renal Pelvis Urothelial Carcinoma, Locally Advanced Ureter

Not yet recruiting
  • Locally Advanced Bladder Urothelial Carcinoma
  • +31 more
  • Diagnostic Laboratory Biomarker Analysis
  • Nivolumab
  • Houston, Texas
    M D Anderson Cancer Center
Aug 18, 2022

Urothelial Carcinoma of the Renal Pelvis and Ureter, Transitional Cell Cancer of the Renal Pelvis and Ureter Trial (ST-02)

Not yet recruiting
  • Urothelial Carcinoma of the Renal Pelvis and Ureter
  • Transitional Cell Cancer of the Renal Pelvis and Ureter
  • (no location specified)
Nov 7, 2023

Stage 0a Renal Pelvis and Ureter Cancer AJCC v8, Stage 0a Renal Pelvis Cancer AJCC v8, Stage 0a Ureter Cancer AJCC v8 Trial in

Active, not recruiting
  • Stage 0a Renal Pelvis and Ureter Cancer AJCC v8
  • +17 more
  • Gemcitabine Hydrochloride
  • Jacksonville, Florida
  • +3 more
Jul 5, 2022

Hydronephrosis, Infiltrating Bladder Urothelial Carcinoma Sarcomatoid Variant, Infiltrating Bladder Urothelial Carcinoma,

Active, not recruiting
  • Hydronephrosis
  • +18 more
  • Durvalumab
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Oct 31, 2022

Tumors of Head, Neck, Thorax, Abdomen, Pelvis and Extremities.

Active, not recruiting
  • Radiation Therapy Complication
  • +2 more
  • Spatially Fractionated Radiation (GRID) Therapy
  • Rochester, Minnesota
    Mayo Clinic in Rochester
Oct 31, 2022

Urothelial Carcinoma, Urothelial Carcinoma Recurrent, Urothelial Carcinoma Ureter Trial (Jelmyto (mitomycin) for pyelocalyceal

Not yet recruiting
  • Urothelial Carcinoma
  • +7 more
  • Jelmyto (mitomycin) for pyelocalyceal solution
  • (no location specified)
May 22, 2023

Renal Cancer Trial in Aarhus N

Enrolling by invitation
  • Renal Cancer
    • Aarhus N, Denmark
      Urology Department Aarhus University Hospital
    Nov 21, 2023

    Renal Tumor Trial

    Not yet recruiting
    • Renal Tumor
      • (no location specified)
      Aug 2, 2023

      Advanced Bladder Urothelial Carcinoma, Advanced Ureter Urothelial Carcinoma, Metastatic Bladder Urothelial Carcinoma Trial in

      Recruiting
      • Advanced Bladder Urothelial Carcinoma
      • +23 more
      • Riverside, California
      • +8 more
      Jul 16, 2022

      Sutureless Zero Ischemia Laparoscopic Tumor Enucleation for T1

      Recruiting
      • Carcinoma, Renal Cell
      • Kidney Neoplasms
        • Yiwu, Zhejiang, China
          The Fourth Affiliated Hospital Zhejiang University School of Med
        Mar 27, 2023

        Renal Mass Biopsy, PEER, and 99mTc-sestamibi SPECT/CT for

        Not yet recruiting
        • Kidney Tumor
        • +2 more
          • (no location specified)
          Feb 6, 2023

          Locally Advanced Renal Pelvis Urothelial Carcinoma, Locally Advanced Ureter Urothelial Carcinoma, Locally Advanced Urethral

          Recruiting
          • Locally Advanced Renal Pelvis Urothelial Carcinoma
          • +20 more
          • Duarte, California
          • +16 more
          Aug 10, 2022

          Locally Advanced Bladder Urothelial Carcinoma, Locally Advanced Renal Pelvis Urothelial Carcinoma, Locally Advanced Ureter

          Recruiting
          • Locally Advanced Bladder Urothelial Carcinoma
          • +13 more
          • Atlanta, Georgia
            Emory University Hospital/Winship Cancer Institute
          Jun 8, 2022

          Clinical Stage III Cutaneous Melanoma AJCC v8, Clinical Stage IV Cutaneous Melanoma AJCC v8, Locally Advanced Bladder Carcinoma

          Recruiting
          • Clinical Stage III Cutaneous Melanoma AJCC v8
          • +41 more
          • Ipilimumab
          • +2 more
          • Houston, Texas
            M D Anderson Cancer Center
          Oct 11, 2022

          PET/MR for Characterization of Renal Masses (RMs)

          Recruiting
          • Renal Tumor
          • +2 more
          • 2-Deoxy-2-[18F]fluoroglucose Positron Emission Tomography/Magnetic Resonance Imaging
          • Dallas, Texas
            University of Texas Southwestern Medical Center
          Oct 5, 2023

          Renal Cancer, Kidney Cancer, Renal Cell Carcinoma Trial in Aurora (Axitinib, Pembrolizumab)

          Not yet recruiting
          • Renal Cancer
          • +3 more
          • Aurora, Colorado
            University of Colorado Cancer Center
          Jul 24, 2023

          Locally Advanced Bladder Urothelial Carcinoma, Locally Advanced Renal Pelvis Urothelial Carcinoma, Locally Advanced Ureter

          Recruiting
          • Locally Advanced Bladder Urothelial Carcinoma
          • +18 more
          • Los Angeles, California
          • +2 more
          Jun 28, 2022

          Advanced Clear Cell Renal Cell Carcinoma, Infiltrating Bladder Urothelial Carcinoma, Plasmacytoid Variant, Infiltrating Bladder

          Active, not recruiting
          • Advanced Clear Cell Renal Cell Carcinoma
          • +35 more
          • Cabozantinib S-malate
          • +2 more
          • Duarte, California
          • +7 more
          Jan 3, 2023

          Pelvis Tumors Trial in Esch-sur-Alzette (Radiation treatment, CK Boost Pelvis)

          Active, not recruiting
          • Pelvis Tumors
          • Radiation treatment
          • CK Boost Pelvis
          • Esch-sur-Alzette, SUD, Luxembourg
            Centre Francois Baclesse
          Jun 20, 2022

          Renal Cancer Trial in Boston (Dendritic Cell Tumor Fusion Vaccine, Granulocyte Macrophage Colony Stimulating Factor (GM-CSF))

          Active, not recruiting
          Has Results
          • Renal Cancer
          • Dendritic Cell Tumor Fusion Vaccine
          • Granulocyte Macrophage Colony Stimulating Factor (GM-CSF)
          • Boston, Massachusetts
            Beth Israel Deaconess Medical Center
          Jan 2, 2023

          Urothelial Cancer of Renal Pelvis, Urothelial Carcinoma of the Renal Pelvis and Ureter, Urothelial Carcinoma Ureter Trial

          Available
          • Urothelial Cancer of Renal Pelvis
          • +5 more
          • Mitomycin for pyelocalyceal solution
          • (no location specified)
          Aug 5, 2022

          Renal Cell Carcinoma Trial (Neoadjuvant Lenvatinib, Neoadjuvant Pembrolizumab, Radical nephrectomy, IVC thrombectomy,

          Not yet recruiting
          • Renal Cell Carcinoma
          • Neoadjuvant Lenvatinib
          • +3 more
          • (no location specified)
          Dec 23, 2022

          Renal Cancer, Tumor, Solid, Kidney Cancer Trial (HistoSonics Edison System)

          Not yet recruiting
          • Renal Cancer
          • +4 more
          • HistoSonics Edison System
          • (no location specified)
          Apr 18, 2023

          Blood and Tissue Samples From Locally Recurrent or Metastatic

          Recruiting
          • Localized Renal Pelvis and Ureter Urothelial Carcinoma
          • +10 more
          • Cytology Specimen Collection Procedure
          • Laboratory Biomarker Analysis
          • Seattle, Washington
            Fred Hutch/University of Washington Cancer Consortium
          Dec 21, 2021